NCT02678377View on ClinicalTrials.gov

The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 26, 2021

Study Completion Date

July 26, 2021

Conditions

Mixed Urinary IncontinenceStress Urinary IncontinenceUrgency Incontinence

Interventions

DRUG

OnabotulinumtoxinA (Botox ®) Injections

OnabotulinumtoxinA (Botox ®) is a neurotoxin, which inhibits acetylcholine release and temporarily relaxes the bladder muscle to inhibit urgency incontinence.

DRUG

Saline Injections

Saline will be injected into the bladder so that investigators are masked to subject randomization.

Trial Locations (1)

60611

Northwestern Medicine Integrated Pelvic Health Clinic, Chicago

All Listed Sponsors

collaborator

Friends of Prentice

OTHER

lead

Northwestern University

OTHER

NCT02678377 - The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence | Biotech Hunter | Biotech Hunter